3020-OL:HK:HK-X DBMSCIUSA (HKD)

COMMON STOCK | Other |

Last Closing

USD 1292.5

Change

0.00 (0.00)%

Market Cap

N/A

Volume

15.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

There is no Profile data available for 3020-OL.HK.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-05 )

Largest Industry Peers for Other

ETFs Containing 3020-OL:HK

IHF iShares U.S. Healthcare P.. 11.37 % 0.43 %

+0.17 (+-0.49%)

N/A
DXZ:CA Dynamic Active U.S. Mid-C.. 11.35 % 0.87 %

+0.07 (+-0.49%)

CAD 0.04B
TETF 6.19 % 0.64 %

N/A

N/A
BOUT Innovator ETFs Trust - In.. 5.99 % 0.80 %

-0.03 (-0.49%)

USD 0.01B
FHI:CA CI Health Care Giants Cov.. 5.16 % 0.75 %

-0.01 (-0.49%)

CAD 0.10B
FHI-B:CA CI Health Care Giants Cov.. 5.16 % 0.00 %

N/A

CAD 0.05B
IAI iShares U.S. Broker-Deale.. 4.32 % 0.42 %

-0.61 (-0.49%)

N/A
MID American Century Mid Cap .. 4.22 % 0.00 %

-0.10 (-0.49%)

USD 0.07B
LCG Sterling Capital Focus Eq.. 4.17 % 0.00 %

-0.06 (-0.49%)

USD 0.03B
LONG:CA CI Global Longevity Econo.. 4.01 % 0.00 %

+0.47 (+-0.49%)

CAD 3.64M
CBUF:XETRA iShares MSCI World Health.. 3.38 % 0.00 %

+0.04 (+-0.49%)

N/A
VSMV VictoryShares US Multi-Fa.. 3.37 % 0.35 %

-0.22 (-0.49%)

USD 0.11B
HDIV 2.83 % 0.00 %

N/A

N/A
TDOC:CA TD Global Healthcare Lead.. 2.25 % 0.00 %

-0.09 (-0.49%)

CAD 0.08B
XHS SPDR® S&P Health Care Se.. 2.17 % 0.35 %

-0.16 (-0.49%)

USD 0.09B
FLXG:LSE Franklin LibertyQ Global .. 1.87 % 0.00 %

N/A

N/A
FRGE:LSE Franklin LibertyQ Global .. 1.87 % 0.00 %

N/A

USD 0.02B
KCE SPDR® S&P Capital Market.. 1.80 % 0.35 %

-0.48 (-0.49%)

N/A
DSTL Distillate US Fundamental.. 1.76 % 0.00 %

-0.21 (-0.49%)

USD 1.79B
RYH 1.72 % 0.40 %

N/A

N/A
HONR 1.20 % 0.65 %

N/A

N/A
CVY Invesco Zacks Multi-Asset.. 1.13 % 0.65 %

-0.17 (-0.49%)

USD 0.10B
SMD 0.45 % 0.10 %

N/A

N/A
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

-0.04 (-0.49%)

USD 0.08B
FXH First Trust Health Care A.. 0.00 % 0.63 %

-0.56 (-0.49%)

USD 0.89B
JKH iShares Morningstar Mid-C.. 0.00 % 0.30 %

N/A

N/A
RYF 0.00 % 0.40 %

N/A

N/A
VVL:CA Vanguard Global Value Fac.. 0.00 % 0.40 %

-0.03 (-0.49%)

N/A
WBIF WBI BullBear Value 3000 E.. 0.00 % 1.05 %

-0.14 (-0.49%)

N/A
XXM:CA 0.00 % 0.68 %

N/A

N/A
FSWD:LSE iShares Edge MSCI World M.. 0.00 % 0.00 %

N/A

N/A
IFSW:LSE iShares Edge MSCI World M.. 0.00 % 0.00 %

N/A

N/A
IBCZ:F iShares IV Public Limited.. 0.00 % 0.00 %

+0.02 (+-0.49%)

N/A
IS07:F iShares IV Public Limited.. 0.00 % 0.00 %

+0.01 (+-0.49%)

N/A
IS07:XETRA iShares Edge MSCI World M.. 0.00 % 0.00 %

-0.01 (-0.49%)

N/A
CBLS Elevation Series Trust 0.00 % 0.00 %

-0.01 (-0.49%)

USD 0.04B
CBSE Elevation Series Trust 0.00 % 0.00 %

-0.23 (-0.49%)

USD 0.02B
IMCG iShares Morningstar Mid-C.. 0.00 % 0.00 %

-0.02 (-0.49%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Other) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.89% 44% F 43% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.89% 44% F 43% F
Trailing 12 Months  
Capital Gain 9.91% 63% D 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.91% 60% D- 62% D
Trailing 5 Years  
Capital Gain 109.65% 85% B 89% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 109.65% 85% B 87% B+
Average Annual (5 Year Horizon)  
Capital Gain 15.32% 77% C+ 75% C
Dividend Return 15.32% 75% C 73% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 18.38% 80% B- 80% B-
Risk Adjusted Return 83.38% 96% N/A 97% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (HKD)

Quarterly Financials (HKD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:

There is nothing we particularly dislike